If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTrifast Regulatory News (TRI)

Share Price Information for Trifast (TRI)

Share Price is delayed by 15 minutes
Get Live Data
79.00    0.00 (0.00%)
Bid:
66.40
Ask:
0.00
Spread: 10.60 (15.964%)
Market Cap: £106.68m
TRI Live PriceLast checked at - London Stock Exchange

Intraday Trifast Share Chart

Director/PDMR Shareholding

23 Oct 2025 17:10

RNS Number : 6419E
Trifast PLC
23 October 2025
 

 

 

23 October 2025

 

 

 

 

 

Trifast plc

(the "Company")

 

Director/PDMR shareholding

 

The following amendment has been made to the 'Director/PDMR shareholding' announcement released on 15 October 2025 at

 15:06hrs under RNS No. 5383D.

 

"Mr Percival has a beneficial interest of 397,274 Ordinary Shares in the Company."

 

All other details remain unchanged.

 

The full amended text is shown below.

 

The Company announces that on 10 October 2025, Mr. Iain Percival, Chief Executive Officer, acquired 5619 ordinary shares of 5 pence each in the Company ("Ordinary Shares"), at a price of 82.2p which were purchased under the Company's Dividend Re-Investment Plan. 

 

On 14 October 2025, Mr. Clive Watson, Senior Independent Non-Executive Director, acquired 1665 ordinary shares of 5 pence each in the Company ("Ordinary Shares") at a price of 82.32p which were purchased under the Company's Dividend Re-Investment Plan. 

 

Following these transactions, Mr. Percival and Mr. Watson have a beneficial interest of 397,274 and 116,478 Ordinary Shares in the Company respectively.

 

Enquiries:

Trifast plc

Christopher Morgan

Company Secretary

Tel: +44 (0) 1825 769696

www.trifast.com

 

 

The notifications below are made in accordance with the requirements of the EU Market Abuse Regulation.

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Iain Percival

 

2.

Reason for the notification

a.

Position/status

Chief Executive Officer

b.

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Trifast plc

 

b.

LEI

213800WFIVE6RWK3CR22

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the financial instrument, type of instrument Identification code

Ordinary shares of 5 pence each 

GB0008883927

b.

Nature of the transaction

Purchase of shares through the Dividend Re-Investment Plan

 

c.

Price(s) and volume(s)

 

Price(s)

Volume(s)

82.2p

5619

d.

Aggregated information

· Aggregated volume

· Price

 

5619

82.2p

e.

Date of the transaction

10 October 2025

 

f.

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

 

 

 

 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Clive Watson

 

2.

Reason for the notification

a.

Position/status

Independent Non-Executive Director

b.

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Trifast plc

 

b.

LEI

213800WFIVE6RWK3CR22

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the financial instrument, type of instrument Identification code

Ordinary shares of 5 pence each 

GB0008883927

b.

Nature of the transaction

Purchase of shares through the Dividend Re-Investment Plan

 

c.

Price(s) and volume(s)

 

Price(s)

Volume(s)

82.32p

1665

d.

Aggregated information

· Aggregated volume

· Price

 

1665

82.32p

e.

Date of the transaction

14 October 2025

f.

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHGZMZGVFNGKZM
Date   Source Headline
23rd Jan 20255:27 pmRNSHolding(s) in Company
11th Dec 20241:58 pmRNSHolding(s) in Company
11th Dec 20241:55 pmRNSDirector/PDMR Shareholding
10th Dec 20243:23 pmRNSTotal Voting Rights
29th Nov 202411:15 amRNSChange of Auditor & Registered office address
21st Nov 20243:09 pmRNSDirector/PDMR Shareholding
19th Nov 20247:00 amRNSHALF-YEARLY FINANCIAL REPORT
22nd Oct 20247:00 amRNSTrading update and Notice of Half-year results
12th Sep 20244:21 pmRNSDirector/PDMR Shareholding
10th Sep 20244:48 pmRNSResult of AGM
10th Sep 20247:01 amRNSAGM Statement
10th Sep 20247:00 amRNSAppointment of CFO
27th Aug 20249:21 amRNSProposed new Directors Remuneration Policy
21st Aug 20249:32 amRNSDirector/PDMR Shareholding
15th Aug 202411:40 amRNSHolding(s) in Company
6th Aug 20243:49 pmRNSPurchase of shares
31st Jul 20244:00 pmRNSAvailability of Annual Report & Notice of Meeting
29th Jul 20247:00 amRNSAnnual Results - 31 March 2024 - Annual Report
23rd Jul 20247:00 amRNSFY24 annual results - date confirmation
2nd Jul 20244:43 pmRNSFY24 results publication–revision of release date
11th Jun 20249:24 amRNSAnnual results presentations
25th Apr 20247:00 amRNSTrading update & Notice of Annual results
15th Apr 20242:11 pmRNSDirector/PDMR Shareholding
15th Apr 20241:07 pmRNSDirector/PDMR Shareholding
4th Apr 202410:40 amRNSBlock listing Interim Review
21st Mar 20247:00 amRNSDirector/PDMR Shareholding - Purchase of shares
13th Mar 20242:30 pmRNSDirector/PDMR Shareholding
11th Mar 20247:00 amRNSAppointment & retirement of non-executive director
22nd Feb 20247:00 amRNSDirectorate Change
9th Feb 20247:00 amRNSHolding(s) in Company
1st Feb 202410:09 amRNSHolding(s) in Company
1st Feb 20247:00 amRNSTotal Voting Rights
31st Jan 20249:33 amRNSHolding(s) in Company
24th Jan 20247:00 amRNSDirector/PDMR Shareholding
23rd Jan 202411:23 amRNSDirector/PDMR Shareholding
22nd Jan 20243:20 pmRNSDirector/PDMR Shareholding
22nd Jan 20247:00 amRNSTrading Update
3rd Jan 20245:50 pmRNSTotal Voting Rights
21st Dec 20234:24 pmRNSHolding(s) in Company
21st Dec 20234:18 pmRNSHolding(s) in Company
15th Dec 20237:00 amRNSNon executive director retirement update
1st Dec 20237:00 amRNSDirector/PDMR Shareholding
30th Nov 20237:00 amRNSPDMR - Performance conditions for LTIP award
24th Nov 20232:34 pmRNSDirector/PDMR shareholding - Purchase of shares
21st Nov 20237:00 amRNSHalf-year Report - six months to 30 September 2023
24th Oct 20237:00 amRNSHalf year trading update and notice of results
19th Oct 20237:00 amRNSNon-executive Director appointment
12th Oct 20237:00 amRNSDirectorate retirement
3rd Oct 20234:16 pmRNSBlock listing Interim Review
25th Sep 20233:49 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.